case report | Q2782326 |
scholarly article | Q13442814 |
P2093 | author name string | Takayuki Suzuki | |
Akira Fujita | |||
Sachie Wada | |||
Koichi Kitazume | |||
Yuri Akagawa | |||
P2860 | cites work | Folotyn (Pralatrexate Injection) for the Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma: U.S. Food and Drug Administration Drug Approval Summary | Q33391588 |
Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study | Q33393701 | ||
Preemptive leucovorin administration minimizes pralatrexate toxicity without sacrificing efficacy | Q33766600 | ||
Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001-2006. | Q34587978 | ||
Phase I/II Study of Pralatrexate in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma | Q38644090 | ||
Pralatrexate: a comprehensive update on pharmacology, clinical activity and strategies to optimize use. | Q39454734 | ||
Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors | Q43609761 | ||
Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas | Q46658608 | ||
Recent Advances in the Treatment of Peripheral T-Cell Lymphoma. | Q52576595 | ||
The outcome of peripheral T-cell lymphoma patients failing first line therapy: a report from the prospective, international T-Cell project. | Q52620959 | ||
Dismal outcome of T-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry | Q87775140 | ||
Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 1: PTCL-NOS, FTCL, AITL, ALCL | Q90775432 | ||
Clinical Activity of Pralatrexate in Patients With Cutaneous T-Cell Lymphoma Treated With Varying Doses of Pralatrexate | Q91287640 | ||
Strategy for Assessing New Drug Value in Orphan Diseases: An International Case Match Control Analysis of the PROPEL Study | Q92281957 | ||
P433 | issue | 2 | |
P921 | main subject | pralatrexate | Q637059 |
peripheral T-cell lymphoma | Q7168693 | ||
Peripheral T-cell lymphoma not otherwise specified | Q7168695 | ||
P304 | page(s) | 529-536 | |
P577 | publication date | 2019-05-01 | |
P1433 | published in | Case reports in oncology | Q27722654 |
P1476 | title | Pralatrexate for Prolonged Treatment of Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, with Prophylactic Leucovorin | |
P478 | volume | 12 |